Suppr超能文献

他们有什么权利?研究的法律特权和同意豁免。

What gives them the right? Legal privilege and waivers of consent for research.

机构信息

1 Department of Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Clin Trials. 2018 Dec;15(6):579-586. doi: 10.1177/1740774518803122. Epub 2018 Oct 3.

Abstract

Waivers of informed consent for research participation are permitted in the United States under the Common Rule, the Health Insurance Portability and Accountability Act regulations, and the US Food and Drug Administration's Exception from Informed Consent rule for emergency research. We assess the novel question regarding what legal right researchers have to carry out research procedures on or about another person, be it experimental medical intervention, psychological or social manipulation, or invasion of privacy, without the permission of their subjects. Our analysis frames waivers of consent as a species of presumed consent, and we address the underlying empirical question of whether it is reasonable to believe that subjects from whom no consent is sought would in fact agree, if asked. A scoping review of what is known about participation and refusal rates in United States-based research suggests that a large minority, on average, do not agree to take part in research. Refusal rates vary widely. This suggests that, while researchers may assert the social utility of their studies are high enough to justify waivers, there is reason to suspect that many who would be enrolled under a waiver of consent would not want to be enrolled. We conclude that waivers should be rare and that institutional review boards and researchers must explicitly address study acceptability in the community at large and the target population of their proposed research.

摘要

在美国,根据《通用规则》、《健康保险携带和责任法案》的规定以及美国食品和药物管理局关于紧急研究的知情同意豁免规则,允许研究参与的知情同意豁免。我们评估了一个新的问题,即研究人员是否有权在未经其研究对象许可的情况下对他人进行研究程序,无论是实验性医疗干预、心理或社会操纵,还是侵犯隐私。我们的分析将同意豁免视为一种假定同意,并解决了一个潜在的经验问题,即如果被询问,是否可以合理地认为没有被征求同意的对象实际上会同意。对美国基于研究的参与率和拒绝率的范围审查表明,平均而言,相当一部分人不同意参与研究。拒绝率差异很大。这表明,尽管研究人员可能声称他们的研究具有足够高的社会效用,可以证明豁免是合理的,但有理由怀疑,许多根据同意豁免被招募的人并不希望被招募。我们的结论是,豁免应该很少见,机构审查委员会和研究人员必须明确解决整个社区和他们拟议研究的目标人群中研究的可接受性问题。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验